1
![Regado Biosciences]()
![Regado Biosciences]()
![Regado Biosciences]()
Regado Biosciences
Leadership team
Chris Rusconi (Founder)
Products/ Services
Biotechnology, Health Care, Therapeutics
Number of Employees
0 - 50
Headquarters
Durham, North Carolina, United States
Established
2001
Traded as
NASDAQ:RGDO
Overview
Location
Summary
Regado Biosciences is a biopharmaceutical company dedicated to developing antithrombotics for use in patients with acute cardiovascular disease.
History
Regado Biosciences was founded in 2005, with a focus on developing novel antithrombotics therapeutic products. The company completed a series of successful financing rounds, totaling more than $100M, bringing together some of the world's leading biotechnology and venture capital firms.
Mission
Regado Biosciences is focused on delivering transformative therapies to improve the treatment of acute cardiovascular diseases with limited treatment options.
Vision
Regado Biosciences' goal is to become a leader in the development of antithrombotics for use in patients with acute cardiovascular diseases.
Key Team
Chris Rusconi (Founder)
Recognition and Awards
Regado Biosciences has been recognized for its efforts in developing breakthrough antithrombotics, winning numerous awards from leading biotechnology and venture capital organizations.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Chris Rusconi (Founder)
Products/ Services
Biotechnology, Health Care, Therapeutics
Number of Employees
0 - 50
Headquarters
Durham, North Carolina, United States
Established
2001
Traded as
NASDAQ:RGDO